Full-Time

Manager Pharmaceutical Repackaging Stability Program

Posted on 11/1/2025

Cardinal Health

Cardinal Health

Distributes pharmaceuticals and medical products globally

Compensation Overview

$105.5k - $145.7k/yr

+ Bonus

Company Does Not Provide H1B Sponsorship

Remote in USA

Remote

Category
Lab & Research (3)
, ,
Requirements
  • Bachelor's degree in a relevant scientific field preferred (e.g., Chemistry).
  • Minimum 8 years of experience in a GMP-regulated pharmaceutical quality oversight environment, with a focus on stability testing and data analysis preferred.
  • In-depth knowledge of FDA regulations, ICH guidelines, USP monographs, and other relevant regulatory requirements related to stability testing and cGMP compliance.
  • Proficiency with Laboratory Information Management Systems (LIMS), electronic quality systems, statistical software and other relevant software applications used for data analysis and reporting, along with good documentation practices.
  • Demonstrated expertise in conducting OOS/OOT investigations, including root cause analysis and CAPA implementation. Experience managing investigations to meet established timelines.
  • Demonstrated expertise with inspections and audits from customers and regulators through active engagement and critical participation.
  • Experience with method transfer and method verification processes.
  • Experience in developing container closure strategy to ensure suitable packaging systems to achieve desirable outcomes is a plus.
  • Proven ability to lead and motivate a team, driving a culture of compliance, quality, and continuous improvement while balancing business goals and operational efficiency.
  • Drives core culture principles of accountability and ownership throughout the team and peers.
  • Experience in utilizing risk-based assessment methodologies that leverage mechanistic insights that may impact the quality and efficacy of drug product stability.
  • Strong problem-solving, analytical, and critical thinking skills, with the ability to identify and resolve complex issues related to stability testing and cGMP compliance in real time.
  • Excellent attention to detail, organizational skills, and the ability to manage multiple projects simultaneously.
  • Exceptional written and verbal communication skills, with the ability to effectively communicate complex scientific information to both technical and non-technical audiences, and to build strong relationships with internal and external business partners.
  • Ability to onboard and engage with external customers and vendors and forge strong working relationships to deliver excellent customer experience.
  • Thorough understanding of cGMP principles and practices, including data integrity requirements.
Responsibilities
  • Program Oversight: Develop, maintain, and oversee the stability program and related studies, ensuring alignment with cGMP requirements and industry best practices.
  • Repackaged Product Stability: Manage the stability program for all repackaged products, ensuring appropriate stability studies are designed and executed to support the shelf life and storage conditions of these products. This includes developing specifications, protocols and acceptance criteria for repackaged products.
  • Documentation: Develop, review, and approve stability protocols for repackaged pharmaceutical products in accordance with regulatory requirements and industry standards. Generate, review, and revise Standard Operating Procedures (SOPs), protocols, reports, and other relevant documentation to ensure compliance with cGMP and regulatory standards.
  • Contract Laboratory Management: Manage third party laboratories executing stability protocols, including oversight of data integrity, adherence to cGMP and performance monitoring.
  • Stability Sample Management: Oversee the shipment of stability samples from repackaging facilities to laboratories and ensuring appropriate sample submission documentation.
  • Data Analysis and Trending: Perform in-depth stability data trending analysis, identify data anomalies, and compile comprehensive reports, ensuring data integrity and compliance with cGMP. Manage the preparation and review of Annual Product Reviews to identify trends, assess product performance, and ensure continued product quality.
  • Container-Closure Selection: Oversee the selection and qualification of appropriate container-closure systems (specifically foil and film for unit dose blisters) to ensure product integrity and stability throughout shelf-life.
  • OOS/OOT Investigations: Lead and conduct thorough Out-of-Specification (OOS) and Out-of-Trend (OOT) investigations related to stability data, including root cause analysis, hypothesis testing, and implementation of corrective and preventive actions (CAPAs) to prevent recurrence. Ensure investigations are initiated and completed in a timely manner, adhering to established timelines and regulatory expectations. Ensure investigations are well-documented, scientifically sound, and compliant with cGMP requirements. Serve as the primary point of contact for escalating quality issues and concerns to the drug manufacturer, ensuring timely resolution and communication.
  • Method Transfer/Verification: Responsible for all method transfer and method verification activities related to stability testing, ensuring successful implementation and validation of analytical methods across multiple laboratories. This includes protocol development, data review, and troubleshooting.
  • Budget Management: Develop and manage the budget for stability testing activities, ensuring cost-effective utilization of resources.
  • Risk Management: Conduct risk assessments related to stability and implement appropriate mitigation strategies.
  • Team Leadership: Lead, mentor, and develop a team of quality professionals. Provide clear direction, set performance expectations, and provide regular feedback. Foster a collaborative and high-performing team environment. Effectively delegate tasks and responsibilities to team members, ensuring appropriate workload distribution and skill development opportunities.
  • Cross-Functional Collaboration: Collaborate with project managers, Inventory Management, Sourcing, and other Quality Assurance team members to ensure seamless execution of stability studies and related activities.
  • Communication: Effectively communicate with internal and external stakeholders, providing updates on stability study progress, addressing technical issues, and ensuring alignment with project timelines and cGMP requirements. Ensure timely responses to inquiries and requests for information.
  • GMP Compliance: Ensure all stability activities are performed in compliance with cGMP regulations, company policies, and industry standards. Participate in internal and external audits, and implement corrective actions as necessary.
Desired Qualifications
  • Bachelor's degree in a relevant scientific field preferred (e.g., Chemistry).

Cardinal Health distributes pharmaceuticals and manufactures medical and laboratory products for hospitals, clinics, and pharmacies worldwide. The company operates a global logistics network to deliver supplies while providing data tools that help healthcare facilities track inventory and improve operational efficiency. Unlike many niche suppliers, Cardinal Health combines 50 years of experience with a massive scale that covers both the physical supply chain and the software needed to manage it. Its goal is to streamline the healthcare supply chain to ensure providers have reliable access to essential products while reducing costs and improving patient care.

Company Size

N/A

Company Stage

N/A

Total Funding

$270.6M

Headquarters

Dublin, California

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • Majority stake in GI Alliance in November 2024 accelerates gastroenterology growth.
  • Acquired Advanced Diabetes Supply Group in November 2024 boosts at-Home Solutions.
  • Added Solaris Health urology MSO in August 2025 to Specialty Alliance platform.

What critics are saying

  • McKesson erodes specialty share with superior pharmacy analytics within 12-24 months.
  • Cencora undercuts generics pricing, squeezing margins in 6-12 months.
  • DEA quotas cut $500M opioid revenue comprising 20% sales in 3-6 months.

What makes Cardinal Health unique

  • Acquired Specialty Networks in January 2024 for multi-specialty GPOs in urology and gastroenterology.
  • Launched Kendall DL™ Multi System in June 2025 for continuous vital signs monitoring.
  • Expanded Actinium-225 production in April 2026 for novel cancer therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Health Savings Account/Flexible Spending Account

401(k) Retirement Plan

401(k) Company Match

Short- and Long-term Disability Coverage

Paid Parental Leave

Wellness Program

Company News

PR Newswire
Jan 31st, 2024
Cardinal Health To Acquire Specialty Networks And Its Pps Analytics Platform, A Technology Enabled Multi-Specialty Group Purchasing And Practice Enhancement Organization In Urology, Rheumatology And Gastroenterology

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices. Transaction creates platform for Cardinal Health expansion across specialty therapeutic areas. Transaction enhances capabilities of Cardinal Health Specialty and supports ongoing build of Navista™ NetworkDUBLIN, Ohio, Jan. 31, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization for $1.2B in cash. Specialty Networks creates clinical and economic value for independent specialty providers and partners across multiple specialty GPOs: UroGPO, Gastrologix and GastroGPO, and United Rheumatology

intelligence360
Mar 7th, 2023
Cardinal Health To Spend $3,100,000.00 To Occupy 3,794 Square Feet Of Space In Indianapolis Indiana.

Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana. Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana.Indianapolis, Indiana — According to state and local economic development sources, Cardinal Health plans to invest $3,100,000.00 to build out 3,794 square feet of new space in Indianapolis. The company plans to occupy the new space at 7736 Zionsville Rd in Indianapolis, on or about September 1, 2023. According to the company website Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled solutions to help our customers thrive in a changing world

GlobeNewswire
Jul 26th, 2022
RxLive Raises $5 Million Series A to Deliver Population Health Telepharmacy Solutions for At-Risk Patients

Digital Health Startup Is Tackling Medication Mismanagement, a $500 Billion Problem...

PR Newswire
Jan 10th, 2022
Medically Home Announces a $110 Million Strategic Investment Led by Baxter International Inc., Global Medical Response and Cardinal Health to Advance Leadership in Hospital-Level Patient Care at Home

/PRNewswire/ -- Medically Home today announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global...

INACTIVE